https://m344inhibitor.com/mens....truation-issues-as-w
Samples for copeptin and hs-cTnI assays were gathered at presentation (0 time) and after 2 hours. The assessed biomarkers were considered unusual whenever hs-cTnI became 26.2 ng/L so when copeptin had been 10 pmol/L. OUTCOMES AMI ended up being diagnosed in 28 patients (10.7%). The NPV of the multi-marker method was 100% (160/160; 95% confidence period [CI], 97.7% to 100%), that was maybe not inferior to compared to serial hs-cTnI measurements (201/201; 100per cent; 95% CI, 98.2% to 100%
Like
Comment
Share
